CytoMed Therapeutics Overview
CytoMed Therapeutics Discounted Cash Flow
DCF Analysis for GDTC.
Get informed when a big investor buys or sells
+ FollowFair Value
$-1.25
Current Fair Value
$-1.25
↓ 213.4% Downside
Overvalued by 213.4% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison